Table 1 Basic information of the study cohort
Variables | Survivor(n = 55) | Non-Survivors(n = 140) | P |
|---|---|---|---|
Age, years | 71.05 ± 14.89 | 70.75 ± 14.81 | 0.001 |
Male, % | 32 (58.2) | 81 (58.0) | 0.967 |
COPD, % | 9(16.4) | 31 (22.1) | 0.368 |
Hypertension, % | 26(47.2) | 61(43,6) | 0.640 |
CVD, % | 9(16.4) | 26(18.6) | 0.718 |
CHF, % | 20(36.4) | 71(50.7) | 0.071 |
DM, % | 15(27.3) | 43(30.7) | 0.636 |
MAP, mmHg | 98(86,108) | 93 (83,103) | 0.040 |
Temperature,°C | 36.4 ± 0.6 | 36.4 ± 2.9 | 0.001 |
HR, beats/min | 94(76,113) | 86(75,101) | 0.088 |
RR, bpm | 20(18,22) | 20(19,23) | 0.035 |
WBC, *10^9/L | 8.7(7.1,13.2) | 9.3(7.0,11.6) | 0.700 |
PLT, *10^9/L | 201(152,302) | 176(136,251) | 0.075 |
Lac, mmol/L | 1.2(1.0, 1.5) | 1.5(1.1, 2.3) | 0.002 |
Scr mmol/L | 72.5(53.2, 84.3) | 64.1(48.5, 84.9) | 0.196 |
ALB g/L | 34.8 ± 8.2 | 32.7 ± 8.6 | 0.001 |
AST U/L | 23.8(18.2, 32.5) | 28.3(19.3, 43.3) | 0.064 |
ALT U/L | 20.3(16.4,25.9) | 22.2(15.6,31.9) | 0.376 |
PCT(ng/ml) | 0.05(0.05,0.07) | 0.05(0.05,1.39) | 0.004 |
CRP(mg/L) | 8(5,35) | 20(8,80) | 0.013 |
sCD40L (pg/ml) | 2194 (1750, 2922) | 2520 (1779, 4203) | 0.043 |
SOFA | 6(5,8) | 7(5,10) | 0.022 |
APACHE II | 16(13,22) | 24(17,33) | 0.001 |